[
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The above statistical analyses were performed using TwoSampleMR package in R.21Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "In other words, the effect of breast size on ER-negative breast cancer risk was no longer significant [ORweighted median: 1.16 (0.95–1.43), and ORweighted mode: 0.94 (0.73–1.23)].Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "An inverse relationship is commonly observed between BMI and premenopausal breast cancer; a positive relationship is commonly observed between BMI and postmenopausal breast cancer.11–14 In terms of cancer subtype, the associations are reported to be stronger for hormone receptor-positive breast cancer in both pre- and post-menopausal women.14–16 However, several Mendelian randomization (MR) analyses showed that BMI predicted by genome-wide association studies (GWAS)-identified variants was inversely associated with the risk of both pre- and post-menopausal breast cancer.17–19\nIn this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In this study, we examined the genetic interplay between BMI, breast size and breast cancer risk (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Results\nBMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Significant relationships (P < 0.05) are denoted by asterisks.BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plot for breast size obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 76 SNP instrumental variables.BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the rest of the 70, 72 and 73 SNP instrumental variables used respectively.Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "BMI is genetically correlated with breast size\nGenetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Genetically predicted BMI and genetically predicted breast size were correlated [correlation coefficient (rg) = 0.50, P = 3.89x10−43] (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online) but none of the other pairs of genetically predicted variables (BMI and breast cancer risk, breast size and breast cancer risk) was found by LDSC to be correlated (P > 0.050).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "As expected, the genetic correlations between the three types of breast cancer (overall, ER-positive, ER-negative) were high (rg > 0.60, all P < 10–85) (Figure 2 and Supplementary Table 5, available as Supplementary data at IJE online).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "BMI has a positive effect on breast size but not vice versa\nA 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between the exposure body mass index (BMI) and two outcomes (breast size and breast cancer risk) based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plot of SNP-breast size associations against SNP-body mass index (BMI) associations with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "A 1-SD increase in genetically predicted BMI was strongly associated with an increase in genetically predicted breast size {odds ratio (ORIVW) [95% confidence interval (CI)]: 2.06 (1.80 − 2.35), P = 1.38x10−26, Figure 3}.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The MR-Egger intercept test (P = 0.964) suggested an absence of strong directional pleiotropy and leave-one-out permutation analysis (Figure 5) did not detect any single SNP that had a strong influence on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "BMI has a negative effect on breast cancer risk but not vice versa\nIn the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nScatter plots of SNP-breast cancer risk associations against SNP-body mass index (BMI) associations for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk with estimates from different Mendelian randomization methods indicated by corresponding coloured lines.Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the IVW analysis, an increase in genetically predicted BMI was strongly associated with a decrease in overall [ORIVW: 0.81 (0.74 − 0.89), P = 9.44x10−6], ER-positive [ORIVW: 0.79 (0.72–0.88), P = 4.84x10−6] and ER-negative [ORIVW: 0.78 (0.67 − 0.91), P = 1.78x10−3] breast cancer risk (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No evidence for directional horizontal pleiotropy was observed (P = 0.095, 0.219 and 0.108 for BMI-overall, BMI-ER-positive and BMI-ER-negative breast cancer risk, respectively) and none of the SNPs had an undue effect on the results (Figure 7a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "One of the SNPs (rs17817449) appeared to have a stronger effect compared with the other SNPs from the leave-one-out analysis (Supplementary Figure 6D–F, available as Supplementary data at IJE online), and this same outlier was also detected through MR-PRESSO, but removing it had a negligible effect on the results.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Unclear relationship between breast size and breast cancer risk\nAn increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nOdds ratios (ORs) and 95% confidence intervals (CI) for the association between breast size and overall breast cancer risk, ER-positive breast cancer risk, and ER-negative breast cancer risk based on the different Mendelian randomization approaches used in this study. *Value based on causal effect estimate from MR-Egger regression; corresponding MR-Egger intercept value testing presence of directional (bias inducing) pleiotropy not shown.Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nLeave-one-out permutation analysis plots for (a) overall breast cancer risk, (b) oestrogen receptor (ER)-positive breast cancer risk, and (c) ER-negative breast cancer risk obtained by leaving out the SNP indicated and repeating the standard inverse-variance weighted method with the six SNP instrumental variables used respectively.Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "An increase in genetically predicted breast size was not significantly associated with breast cancer risk [ORIVW: 1.23 (0.78−1.95), P = 0.370, 1.19 (0.81–1.74), P = 0.373 and 1.32 (0.69−2.55), P = 0.405 for overall, ER-positive and ER-negative breast cancer risk, respectively] (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "No directional pleiotropic effect was detected as MR-Egger intercept tests did not differ significantly from zero (P = 0.991, 0.891 and 0.836 for size-overall, size-ER-positive and size-ER-negative breast cancer risk, respectively), and no outliers were detected by leave-one-out permutation analysis (Figure 10a–c).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "Panel a",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Discussion\nIn this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "In this study, we found potential causal genetic evidence linking BMI to both breast size and breast cancer risk (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  }
]